Dear Colleagues,
Gender analysis has recently obtained renewed attention not only from
regulatory authorities, but also by the USA Senate and the press. In
our forthcoming Nice Congress the Industrial Pharmacy Section wants
to devote one or two sessions to this gender analysis together with
some other disciplines.
I would appreciate to obtain suggestions for presentations and
speakers especially in Europa, Asia or South-America. Furthermore I
would be very interested to hear from industries what specific
information their analysis has rendered in the past. Most of it will
not be published, but we all would benefit tremendously if we would
have new industrial data published on gender analysis of clinical
trial outcomes, both on the PK and PD level.
I appreciate any reaction.
Kind regards,
Tom Sam
President Industrial Pharmacy Section
--------------------------------------------
Tom Sam
a.sam@hccnet.nl
Industrial Pharmacy Section FIP
--------------------------------------------
|